The company licensed technology from MIT and subsequently advanced the cellular logic gates so they could work with multiple ...

AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...

The new treatment, which uses a type of immune cell called natural killer cells, promoted complete remission in several ...

A ready-made version of a cutting-edge cancer immunotherapy can effectively defeat blood cancers, a new study says.

A phase 1 trial evaluating SENTI-202 demonstrated positive preliminary results in treating relapsed/refractory acute myeloid ...

At this time, I would like to welcome everyone to today's Gates Industrial Corporation Q1 2025 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' ...

The Motley Fool. DATE Thursday, Apr 24, 2025 Read More: Earn up to $845 cash back this year just by changing how you pay at Costco! Learn more here. CALL PARTICIPANTS Daniel O'Day: Chairman and Chief ...